| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-06 |
| mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
4e-05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |